# Molecular Screening for Cancer Treatment Optimization

> **NCT01566019** · NA · UNKNOWN · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 2150 (estimated)

## Conditions studied

- Metastatic Solid Tumors (Any Localization)

## Interventions

- **PROCEDURE:** Tumoral biopsy

## Key facts

- **NCT ID:** NCT01566019
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-10-28
- **Primary completion:** 2020-10
- **Final completion:** 2020-10
- **Target enrollment:** 2150 (ESTIMATED)
- **Last updated:** 2020-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01566019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01566019, "Molecular Screening for Cancer Treatment Optimization". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01566019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*